Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Expands European, Asian Operations

NEW YORK, Aug. 19 (GenomeWeb News) - Gene Logic, based in Gaithersburg, Md., said yesterday that it has expanded its European operations and established a new subsidiary in Japan.

 

Gene Logic said that it added sales and support staff to its London-based European office, and hired a business development representative to be based in Germany. In addition, the company established a wholly owned subsidiary in Japancalled Gene Logic K.K. to provide marketing and customer support to the region.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.